APA (7th ed.) Citation

Kamimura, S., Ishitani, K., Morozumi, R., Fujii, T., & Kitamura, Y. (2025). High Remission Rate in Eosinophilic Chronic Rhinosinusitis Following More Than Two Years of Dupilumab Therapy. Laryngoscope Investigative Otolaryngology, 10(6), 1. https://doi.org/10.1002/lio2.70311

Chicago Style (17th ed.) Citation

Kamimura, Seiichiro, Keisuke Ishitani, Ryota Morozumi, Tatsuya Fujii, and Yoshiaki Kitamura. "High Remission Rate in Eosinophilic Chronic Rhinosinusitis Following More Than Two Years of Dupilumab Therapy." Laryngoscope Investigative Otolaryngology 10, no. 6 (2025): 1. https://doi.org/10.1002/lio2.70311.

MLA (9th ed.) Citation

Kamimura, Seiichiro, et al. "High Remission Rate in Eosinophilic Chronic Rhinosinusitis Following More Than Two Years of Dupilumab Therapy." Laryngoscope Investigative Otolaryngology, vol. 10, no. 6, 2025, p. 1, https://doi.org/10.1002/lio2.70311.